Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantation
References (21)
Cyclosporin in cadaveric renal transplantation: one-year follow-up of a multicentre trial
Lancet
(1983)- et al.
Cyclosporin A in patients receiving renal allografts from cadaver donors
Lancet
(1978) - et al.
Cyclosporin treatment with conversion after three months versus conventional immunosuppression in renal allograft recipients
Lancet
(1987) - et al.
Cyclosporin conversion versus conventional immunosuppression: long-term follow-up and histological evaluation
Lancet
(1987) - et al.
The adverse impact of cyclosporine on serum lipids in renal transplant recipients
Am J Kidney Dis
(1991) - et al.
Prolonged survival of human-kidney homografts by immunosuppressive drug therapy
N Engl J Med
(1963) A randomized clinical trial of cyclosporine in cadaveric renal transplantation
N Engl J Med
(1983)- et al.
Chronic irreversible nephrotoxicity from cyclosporin A
Nephron
(1985) - et al.
Controlled cyclosporine conversion at three months after renal transplantation
Transplantation
(1988) - et al.
High- and low-dose regimens of cyclosporine in renal transplantation: immunosuppressive efficacy and side effects
Nephrol Dial Transplant
(1988)
There are more references available in the full text version of this article.
Cited by (159)
Clinical gout
2015, Rheumatology: Sixth EditionComplete remission of diabetic nephropathy in a type 1 diabetic patient with near-nephrotic range proteinuria and reduced renal function
2009, Diabetes Research and Clinical PracticeMycophenolate mofetil attenuates pulmonary arterial hypertension in rats
2006, Biochemical and Biophysical Research CommunicationsEfficacy of mycophenolic acid combined with KRP-203, a novel immunomodulator, in a rat heart transplantation model
2006, Journal of Heart and Lung Transplantation
Copyright © 1995 Published by Elsevier Ltd.